Management of Patients With Pancreatic Cancer Using the "Right Track" Model

被引:12
作者
Rosenzweig, Allison [1 ]
Berlin, Jordan [2 ]
Chari, Suresh [3 ]
Kindler, Hedy [4 ]
Matrisian, Lynn [1 ]
Mayoral, Allison [1 ]
Mills, Jeannine [5 ]
Nissen, Nicholas [6 ]
Picozzi, Vincent [7 ]
Zelada-Arenas, Fatima [1 ]
Fleming, Jason [8 ]
机构
[1] Pancreat Canc Act Network, Sci & Med Affairs, Los Angeles, CA USA
[2] Vanderbilt Ingram Canc Ctr, Dept Hematol Oncol, Nashville, TN USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA
[4] Univ Chicago, Dept Gastrointestinal Oncol, Chicago, IL 60637 USA
[5] Dartmouth Hitchcock Med Ctr & Clin, Oncol Nutr Serv, Lebanon, NH USA
[6] Cedars Sinai Med Ctr, Dept Surg Gen Surg, Los Angeles, CA 90048 USA
[7] Virginia Mason Med Ctr, Dept Hematol & Med Oncol, Seattle, WA 98101 USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA
关键词
pancreatic cancer; guidelines; PanCAN; position statement; Right Track model; REPORTED OUTCOMES; SOLID TUMORS; HOSPITAL VOLUME; CLINICAL-TRIALS; ONCOLOGY CARE; SURVIVAL; EFFICACY; THERAPY; STAGE; ADENOCARCINOMA;
D O I
10.1093/oncolo/oyad080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer is one of the few cancer types in the US with incidence and death rates continuing to rise. As the disease threatens to become the second leading cause of cancer-related deaths in the country, it is imperative to review the best practices currently available to extend and improve patient lives. To provide a roadmap for healthcare professionals detecting, diagnosing, and caring for patients with pancreatic cancer as a supplement to national guidelines focused on recommended treatment regimens, the Pancreatic Cancer Action Network (PanCAN)'s Scientific and Medical Affairs staff and expert Scientific and Medical Advisory Board have created a series of position statements. The statements are based upon scientific evidence and clinical observations published in the literature and research conducted through PanCAN's internal programs and initiatives. This review summarizes the rationale and sources for these position statements related to diagnosis, treatment, and care for pancreatic cancer and provides information about resources to make these recommendations accessible to patients and their medical teams. Pancreatic cancer is a complex and extremely challenging disease. Beyond treatment recommendations outlined in national guidelines, steps can be taken to help patients feel better and live longer. Under the framework of the "Right Track" model-right team, right tests, right treatments, data sharing-PanCAN's position statements can provide supplementary guidance to healthcare professionals for the short- and longterm management of patients with the disease.
引用
收藏
页码:584 / 595
页数:12
相关论文
共 78 条
[1]  
Accelerator KPM, FRAM DRIV PAT VAL
[2]   Defining a Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy in the United States [J].
Adam, Mohamed Abdelgadir ;
Thomas, Samantha ;
Youngwirth, Linda ;
Pappas, Theodore ;
Roman, Sanziana A. ;
Sosa, Julie A. .
JAMA SURGERY, 2017, 152 (04) :336-342
[3]   Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial [J].
Bakitas, Marie A. ;
Tosteson, Tor D. ;
Li, Zhigang ;
Lyons, Kathleen D. ;
Hull, Jay G. ;
Li, Zhongze ;
Dionne-Odom, J. Nicholas ;
Frost, Jennifer ;
Dragnev, Konstantin H. ;
Hegel, Mark T. ;
Azuero, Andres ;
Ahles, Tim A. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) :1438-1445
[4]   Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients [J].
Barkin, Jodie A. ;
Westermann, Amy ;
Hoos, William ;
Moravek, Cassadie ;
Matrisian, Lynn ;
Wang, Hongwei ;
Shemanski, Lynn ;
Barkin, Jamie S. ;
Rahib, Lola .
PANCREAS, 2019, 48 (06) :780-786
[5]   Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial [J].
Basch, Ethan ;
Pugh, Stephanie L. ;
Dueck, Amylou C. ;
Mitchell, Sandra A. ;
Berk, Lawrence ;
Fogh, Shannon ;
Rogak, Lauren J. ;
Gatewood, Marcha ;
Reeve, Bryce B. ;
Mendoza, Tito R. ;
O'Mara, Ann M. ;
Denicoff, Andrea M. ;
Minasian, Lori M. ;
Bennett, Antonia V. ;
Setser, Ann ;
Schrag, Deborah ;
Roof, Kevin ;
Moore, Joan K. ;
Gergel, Thomas ;
Stephans, Kevin ;
Rimner, Andreas ;
DeNittis, Albert ;
Bruner, Deborah Watkins .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02) :409-418
[6]   Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial [J].
Basch, Ethan ;
Deal, Allison M. ;
Kris, Mark G. ;
Scher, Howard I. ;
Hudis, Clifford A. ;
Sabbatini, Paul ;
Rogak, Lauren ;
Bennett, Antonia V. ;
Dueck, Amylou C. ;
Atkinson, Thomas M. ;
Chou, Joanne F. ;
Dulko, Dorothy ;
Sit, Laura ;
Barz, Allison ;
Novotny, Paul ;
Fruscione, Michael ;
Sloan, Jeff A. ;
Schrag, Deborah .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) :557-+
[7]   KRYSTAL-1: Updated activity and safety of adagrasib (MRTX849) in patients (Pts) with unresectable or metastatic pancreatic cancer (PDAC) and other gastrointestinal (GI) tumors harboring a KRASG12C mutation [J].
Bekaii-Saab, Tanios S. ;
Spira, Alexander I. ;
Yaeger, Rona ;
Buchschacher, Gary L. ;
McRee, Autumn Jackson ;
Sabari, Joshua K. ;
Johnson, Melissa Lynne ;
Barve, Minal A. ;
Hafez, Navid ;
Velastegui, Karen ;
Christensen, James G. ;
Kheoh, Thian ;
Der-Torossian, Hirak ;
Rybkin, Igor I. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[8]   National failure to operate on early stage pancreatic cancer [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
ANNALS OF SURGERY, 2007, 246 (02) :173-180
[9]  
Boyd Andrew D, 2007, J Natl Compr Canc Netw, V5, P113
[10]   Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma [J].
Aguirre, Andrew J. ;
Hruban, Ralph H. ;
Raphael, Benjamin J. .
CANCER CELL, 2017, 32 (02) :185-+